Clinical Trial Update: De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial conducted by Fudan University evaluating de-escalation therapy for stage I ER-positive breast cancer; the study is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Phase 3 | Status: NOT_YET_RECRUITING